Helicobacter Bacteremia

The FDA has rejected Phathom Pharmaceutical’s vonoprazan new drug application for erosive esophagitis, as well as its post-approval supplement for Helicobacter pylori, due to the presence of nitrosamine impurities.

LAS VEGAS – Using next generation sequencing through stool samples to predict Helicobacter pylori antibiotic resistance offered rapid results equivalent to those from gastric biopsies, according to a presentation at the ACG Scientific Meeting.